Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.05 USD | -0.10% | +0.45% | +12.17% |
May. 21 | GCM Grosvenor Invests in Healthcare Investment Firm | MT |
May. 21 | Invidia Capital Management announced that it has received funding from GCM Grosvenor Inc. | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 368.2 | 531.7 | 462.4 | 321.4 | 385.2 | 444.4 | - | - |
Enterprise Value (EV) 1 | 368.2 | 531.7 | 462.4 | 321.4 | 385.2 | 444.4 | 444.4 | 444.4 |
P/E ratio | - | 74 x | 37.5 x | 27.2 x | 131 x | 47.9 x | 21.4 x | - |
Yield | - | - | 3.81% | - | 4.91% | 4.98% | 5.8% | 7.16% |
Capitalization / Revenue | 0.88 x | 1.24 x | 0.87 x | 0.72 x | 0.87 x | 0.88 x | 0.76 x | - |
EV / Revenue | 0.88 x | 1.24 x | 0.87 x | 0.72 x | 0.87 x | 0.88 x | 0.76 x | - |
EV / EBITDA | - | 3.62 x | 2.58 x | 2.15 x | 2.37 x | 2.23 x | 1.94 x | - |
EV / FCF | - | 7.95 x | 2.59 x | 1.49 x | 4.36 x | 22.2 x | 19.3 x | - |
FCF Yield | - | 12.6% | 38.5% | 67.1% | 22.9% | 4.5% | 5.18% | - |
Price to Book | - | - | - | -71.5 x | -46.8 x | 5.37 x | 1.93 x | 1.08 x |
Nbr of stocks (in thousands) | 35,923 | 39,915 | 44,036 | 42,239 | 42,989 | 44,223 | - | - |
Reference price 2 | 10.25 | 13.32 | 10.50 | 7.610 | 8.960 | 10.05 | 10.05 | 10.05 |
Announcement Date | 8/7/20 | 2/25/21 | 2/15/22 | 2/14/23 | 2/13/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 416.4 | 430 | 531.6 | 446.5 | 445 | 505.3 | 583.7 | - |
EBITDA 1 | - | 147 | 179.1 | 149.3 | 162.2 | 198.9 | 229.2 | - |
EBIT 1 | - | 144.7 | 177.4 | 147.8 | 160.8 | 203.5 | 235.2 | - |
Operating Margin | - | 33.66% | 33.38% | 33.1% | 36.14% | 40.28% | 40.29% | - |
Earnings before Tax (EBT) 1 | - | -63.12 | 153.1 | 89.09 | -21.51 | 69.9 | 120.8 | - |
Net income 1 | 46.78 | -100.8 | 21.48 | 19.82 | 12.77 | 17 | 20.6 | - |
Net margin | 11.23% | -23.45% | 4.04% | 4.44% | 2.87% | 3.36% | 3.53% | - |
EPS 2 | - | 0.1800 | 0.2800 | 0.2800 | 0.0682 | 0.2100 | 0.4700 | - |
Free Cash Flow 1 | - | 66.86 | 178.2 | 215.7 | 88.3 | 20 | 23 | - |
FCF margin | - | 15.55% | 33.53% | 48.31% | 19.84% | 3.96% | 3.94% | - |
FCF Conversion (EBITDA) | - | 45.47% | 99.49% | 144.45% | 54.45% | 10.05% | 10.03% | - |
FCF Conversion (Net income) | - | - | 829.65% | 1,088.45% | 691.26% | 117.65% | 111.65% | - |
Dividend per Share 2 | - | - | 0.4000 | - | 0.4400 | 0.5000 | 0.5825 | 0.7200 |
Announcement Date | 8/7/20 | 2/25/21 | 2/15/22 | 2/14/23 | 2/13/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 190.6 | 105.1 | 104.4 | 137.2 | 99.83 | 99.12 | 107.6 | 121.7 | 116.6 | 108.9 | 117.1 | 126 | 155 | 126.1 | 133.7 |
EBITDA 1 | 80.63 | 37.17 | 35.24 | 41.37 | 35.58 | 32.89 | 36 | 43.56 | 49.73 | 42.37 | 43.4 | 47.97 | 65.17 | 49.4 | 53.2 |
EBIT 1 | 80.23 | 36.77 | 34.84 | 28.73 | 35.21 | 32.54 | 22.37 | - | 49.42 | 42.06 | 41.6 | 47.9 | 65.7 | 48.5 | 52.3 |
Operating Margin | 42.09% | 34.97% | 33.38% | 20.94% | 35.27% | 32.83% | 20.78% | - | 42.4% | 38.64% | 35.53% | 38% | 42.37% | 38.46% | 39.12% |
Earnings before Tax (EBT) 1 | 84.53 | 25.56 | 32.69 | 16.95 | 13.88 | -14.72 | -34.2 | 20.66 | 6.453 | -17.8 | 23.4 | 27.2 | 37.1 | - | - |
Net income 1 | 14.22 | 31.71 | 32.56 | 3.099 | 4.39 | 30.38 | 32.8 | 5.898 | 3.258 | 2.124 | 3.8 | 4.5 | 6.6 | - | - |
Net margin | 7.46% | 30.16% | 31.2% | 2.26% | 4.4% | 30.65% | 30.48% | 4.85% | 2.8% | 1.95% | 3.25% | 3.57% | 4.26% | - | - |
EPS 2 | 0.2900 | 0.0800 | 0.1300 | 0.0200 | 0.0500 | 0.1628 | 0.1744 | 0.0400 | 0.0174 | 0.0113 | 0.0900 | 0.1000 | 0.1500 | - | - |
Dividend per Share 2 | 0.1000 | 0.1000 | 0.1000 | 0.1100 | - | 0.1100 | 0.1100 | 0.1100 | 0.1100 | - | 0.1300 | 0.1300 | 0.1333 | 0.1400 | 0.1650 |
Announcement Date | 2/15/22 | 5/10/22 | 8/9/22 | 11/9/22 | 2/14/23 | 5/10/23 | 8/9/23 | 11/8/23 | 2/13/24 | 5/7/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | 66.9 | 178 | 216 | 88.3 | 20 | 23 | - |
ROE (net income / shareholders' equity) | - | - | - | - | -53.8% | 500% | 114% | 66.6% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | - | -0.1100 | -0.1900 | 1.870 | 5.210 | 9.330 |
Cash Flow per Share | - | - | - | 1.150 | - | - | - | - |
Capex | - | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 8/7/20 | 2/25/21 | 2/15/22 | 2/14/23 | 2/13/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.17% | 444M | |
+6.61% | 8.9B | |
-26.92% | 3.47B | |
+9.34% | 3.36B | |
+34.90% | 2.82B | |
+14.82% | 2.56B | |
+39.87% | 2.13B | |
+31.40% | 1.74B | |
+33.57% | 1.72B | |
+4.85% | 1.39B |
- Stock Market
- Equities
- GCMG Stock
- Financials GCM Grosvenor Inc.